This monitor provides an overview of the most important results of the cervical cancer screening for the period between February 2022 and November 2023.

The first results are:

• a properly set up screening process on each island that is tailored to that island’s specific situation;
• the availability of information materials, allowing people to make an informed decision about participation;
• training or refresher courses for those who perform the cervical swab tests on all islands; 1 The key figures for the first year of breast cancer screening on Bonaire were summarized in 2022 in a monitor for 2021–2022.
• all analyses are performed by a single accredited laboratory on Curaçao. This laboratory carries out both the test for the human papilloma virus (HPV typing) and the cytology test for cancer cells;
• a number of tasks have been delegated to local and regional partners , such as information provision and sampling. The RIVM screening organization remains responsible for monitoring the entire screening process;
• a screening process that follows the guidelines applicable in the European Netherlands as much as possible.